M. Milanese (Pietra ligure (SV), Italy), E. Derom (Ghent, Belgium)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Analysis of spontaneous breathing can predict abnormal lung function in asthma
F. Beaufils (Bordeaux, France), P. Girodet (Bordeaux, France), C. Pison (Grenoble, France), P. Hanusse (Bordeaux, France), J. Joie (Bordeaux, France), T. Similowski (Paris, France), P. Laveneziana (Paris, France), R. Marthan (Bordeaux, France), P. Berger (Bordeaux, France)
|   |
Active asthma and longer disease duration associated with more hyperinflation and increased diffusion capacity – TRAIL Cohort
C. Schultz (Hvidovre, Denmark), O. Tupper (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark)
| |
Airway hyperresponsiveness in adult patients with and without allergies
G. Strazda (Riga, Latvia), N. Jurka (Riga, Latvia), O. Madaja (Riga, Latvia), I. Taivans (Riga, Latvia)
| |
The Frequency of Small Airway Dysfunction and Its Relationship with Disease Control in Chronic Airway Diseases
D. Polat Yulug (Mersin, Turkey), S. Atis Nayci (Mersin, Turkey), B. Tasdelen (Mersin, Turkey), E. Ozgur (Mersin, Turkey), C. Ozge (Mersin, Turkey)
| |
Comparison of two forced oscillation devices in adults with respiratory disorders
M. Crutsen (Maastricht, Netherlands), J. Baars (Maastricht, Netherlands), L. Conemans (Maastricht, Netherlands), S. Simons (Maastricht, Netherlands)
| |
The effect of diurnal variation in exercise-induced bronchoconstriction
A. Rowe (Dublin, Ireland), N. Mahony (Dublin, Ireland), N. Fleming (Dublin, Ireland)
| |
Association between seasonal patterns of the airway response to humid air and dynamics of lung function and disease control in asthma patients
E. Afanaseva (Blagoveshchensk (Amur Oblast), Russian Federation), D. Naumov (Blagoveshchensk (Amur Oblast), Russian Federation), O. Kotova (Blagoveshchensk (Amur Oblast), Russian Federation), D. Gassan (Blagoveshchensk (Amur Oblast), Russian Federation), E. Sheludko (Blagoveshchensk (Amur Oblast), Russian Federation), A. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
Relationship between respiratory exchange ratio and pulmonary function in patients with obstructive lung disease
J. Lee (Goyang-si, Republic of Korea), S. Jeon (Goyang-si, Republic of Korea), S. Kang (Seoul, Republic of Korea), Y. Lee (Seoul, Republic of Korea)
| |
Salbutamol or ipratropium bromide: does gender and age influence the response to drugs?
L. Raposo (Lisboa, Portugal), R. Barros (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
| |
Improving the appropriate use of Mannitol challenge testing in a large teaching hospital.
J. Bradley (Leeds, United Kingdom), L. Lear (Leeds, United Kingdom), T. Sutherland (Leeds, United Kingdom)
| |
Asthma and peripheral airway obstruction
R. Barros (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
| |
Use of Lung Clearance Index (LCI) to distinguish asthmatics within a symptomatic population.
L. Healy (Manchester, United Kingdom), C. Murray (Manchester, United Kingdom), A. Simpson (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), S. Drake (Manchester, United Kingdom), R. Wang (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), J. Sale (Manchester, United Kingdom), R. Tudge (Manchester, United Kingdom), G. Kerry (Manchester, United Kingdom), L. Lowe (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom)
| |
Bronchodilator responsiveness over time in SPIROMICS: Clinical characteristics
C. Cooper (Los Angeles, United States of America), S. Fortis (Iowa, United States of America), D. Couper (Chapel Hill, United States of America), M. Quibrera (Chapel Hill, United States of America), M. Arjomandi (San Francisco, United States of America), I. Barjaktarevic (Los Angeles, United States of America), G. Barr (New York, United States of America), S. Bhatt (Birmingham, United States of America), R. Bowler (Denver, United States of America), J. Curtis (Ann Arbor, United States of America), M. Dransfield (Birmingham, United States of America), B. Drummond (Chapel Hill, United States of America), M. Han (Ann Arbor, United States of America), N. Hansel (Baltimore, United States of America), A. Hastie (Winston Salem, United States of America), E. Hoffman (Iowa City, United States of America), R. Kanner (Salt Lake City, United States of America), V. Kim (Philadelphia, United States of America), J. Krishnan (Chicago, United States of America), S. Lazarus (San Francisco, United States of America), F. Martinez (Omaha, United States of America), V. Ortega (Winston Salem, United States of America), R. Paine (Salt Lake City, United States of America), S. Peters (Winston Salem, United States of America), S. Rennard (Omaha, United States of America), D. Tashkin (Los Angeles, United States of America), P. Woodruff (San Francisco, United States of America), W. Anderson (Chapel Hill, United States of America)
| |
Prevalence of pre-operative airflow obstruction in high risk patients without prior COPD diagnosis
T. Chambers (London, United Kingdom), W. Ricketts (London, United Kingdom), R. Singh (London, United Kingdom), M. Gooneratne (London, United Kingdom)
| |
Changes in FEV1 and SpO2 in patients with severe and very severe COPD
A. Henriksen (Trondheim, Norway), A. Rabe (Trondheim, Norway), M. Bjoerstad Ringset (Trondheim, Norway)
| |
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
K. Kahnert (München, Germany), R. Jörres (München, Germany), A. Schneider (München, Germany), P. Alter (Marburg, Germany), H. Kauczor (Heidelberg, Germany), B. Jobst (Heidelberg, Germany), J. Biederer (Heidelberg, Germany), R. Bals (Homburg, Germany), H. Watz (Großhansdorf, Germany), J. Behr (Munich, Germany), D. Kauffmann-Guerrero (Munich, Germany), J. Lutter (Munich, Germany), A. Hapfelmeier (Munich, Germany), H. Magnussen (Großhansdorf, Germany), F. Trudzinski (Heidelberg, Germany), T. Welte (Hannover, Germany), C. Vogelmeier (Marburg, Germany), C. Kellerer (Marburg, Germany)
| |
Duration and frequency of spirometry needed to accurately reflect longitudinal change of FEV1 in COPD
J. Wilkinson (Los Angeles, United States of America), I. Barjaktarevic (Los Angeles, United States of America), H. Wilhalme (Los Angeles, United States of America), C. Cooper (Los Angeles, United States of America), D. Tashkin (Los Angeles, United States of America)
| |
Classification of lung function trajectories in SPIROMICS
W. Anderson (Chapel Hill, NC, United States of America), M. Quibrera (Chapel Hill, NC, United States of America), D. Couper (Chapel Hill, NC, United States of America), M. Arjomandi (San Francisco, CA, United States of America), I. Barjaktarevic (Los Angeles, CA, United States of America), G. Barr (New York, NY, United States of America), S. Bhatt (Birmingham, AL, United States of America), M. Dransfield (Birmingham, AL, United States of America), B. Drummond (Chapel Hill, NC, United States of America), M. Han (Ann Arbor, MI, United States of America), N. Hansel (Baltimore, MD, United States of America), A. Hastie (Wake Forest, NC, United States of America), E. Hoffman (Iowa City, IA, United States of America), R. Kanner (Salt Lake City, UT, United States of America), V. Kim (Philadelphia, PA, United States of America), S. Lazarus (San Francisco, CA, United States of America), V. Ortega (Wake Forest, NC, United States of America), R. Paine (Wake Forest, NC, United States of America), S. Rennard (Omaha, NE, United States of America), D. Tashkin (Los Angeles, CA, United States of America), P. Woodruff (San Francisco, CA, United States of America), C. Cooper (Los Angeles, CA, United States of America)
| |
Improved spirometric index to discriminate the severity of centrilobular emphysema
T. Shimada (Tsukuba, Japan), H. Iijima (Tsukuba, Japan), Y. Shiraishi (Kyoto, Japan), F. Mochizuki (Tsukuba, Japan), T. Naito (Tsukuba, Japan), H. Shima (Kyoto, Japan), K. Terada (Himeji, Japan), S. Sato (Kyoto, Japan), S. Muro (Kashihara, Japan), T. Hirai (Kyoto, Japan), N. Hizawa (Tsukuba, Japan), N. Tanabe (Kyoto, Japan)
| |
Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS
M. Arjomandi (San Francisco, United States of America), J. Chen (San Francisco, United States of America), I. Barjaktarevic (Los ángeles, United States of America), R. Barr (New York, United States of America), E. Bleecker (Tuscon, United States of America), R. Bowler (Denver, United States of America), R. Buhr (Los Angeles, United States of America), A. Comellas (Iowa City, United States of America), D. Couper (Chapel Hill, United States of America), J. Curtis (Ann Arbor, United States of America), M. Dransfield (Birmingham, United States of America), M. Drummond (Chapel Hill, United States of America), S. Fortis (Iowa City, United States of America), M. Han (Ann Arbor, United States of America), N. Hansel (Baltimore, United States of America), E. Hoffman (Iowa City, United States of America), R. Kanner (Salt Lake City, United States of America), J. Krishnan (Chicago, United States of America), W. Labaki (Ann Arbor, United States of America), S. Lazarus (San Francisco, United States of America), F. Martinez (New York, United States of America), V. Ortega (Winston Salem, United States of America), R. Paine (Salt Lake City, United States of America), S. Peters (Winston Salem, United States of America), J. Schroeder (Salt Lake City, United States of America), S. Rennard (Cambridge, United Kingdom), P. Woodruff (San Francisco, United States of America), D. Tashkin (Los Angeles, United States of America), C. Cooper (Los Angeles, United States of America)
| |